112 related articles for article (PubMed ID: 6932739)
1. Bone marrow damage due to melphalan and other cytostatic agents.
Bezwoda WR; Hofman K; Bothwell TH; Derman DP; MacPhail AP; Mendelow B
S Afr Med J; 1980 Sep; 58(12):479-84. PubMed ID: 6932739
[TBL] [Abstract][Full Text] [Related]
2. Radiation and drug therapies, and leukemia.
Potolsky A; Creger WP
Annu Rev Med; 1973; 24():75-82. PubMed ID: 4514215
[No Abstract] [Full Text] [Related]
3. Multiple myeloma and acute leukemia associated with alkylating agents.
Kyle RA; Pierre RV; Bayrd ED
Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
[TBL] [Abstract][Full Text] [Related]
4. [Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)].
Ortonne JP; Thivolet J; Chouvet B; Coiffet J
Ann Dermatol Venereol; 1979 Mar; 106(3):251-6. PubMed ID: 290349
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan.
Meytes D; Katz DR
Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846
[No Abstract] [Full Text] [Related]
6. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
8. [Induced malignant hemopathies. 6 new cases with 1 patient surviving 45 months].
Clément F
Schweiz Med Wochenschr; 1979 Apr; 109(15):544-51. PubMed ID: 286415
[TBL] [Abstract][Full Text] [Related]
9. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
10. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
[TBL] [Abstract][Full Text] [Related]
11. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
Bell DR; Woods RL; Levi JA
Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
[No Abstract] [Full Text] [Related]
12. High-dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias.
Maraninchi D; Pico JL; Hartmann O; Gastaut JA; Kamioner D; Hayat M; Mascret B; Beaujean F; Sebahoun G; Novakovitch G
Cancer Treat Rep; 1986 Apr; 70(4):445-8. PubMed ID: 3516394
[TBL] [Abstract][Full Text] [Related]
13. Acute leukemia after alkylating-agent therapy of ovarian cancer.
Reimer RR; Hoover R; Fraumeni JF; Young RC
N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemia after melphalan treatment for ovarian carcinoma.
Blythe JC
J Med Assoc State Ala; 1977 Nov; 47(5):42-3, 57. PubMed ID: 925549
[No Abstract] [Full Text] [Related]
15. [Plasmocytoma, alkylating agents, and acute myeloid leukemia (author's transl)].
Schmalzl F; Keiser G; Kresbach E; Fritz H; Asamer H; Braunsteiner H
Dtsch Med Wochenschr; 1975 Sep; 100(39):1961-7. PubMed ID: 1057506
[TBL] [Abstract][Full Text] [Related]
16. [Erythroleukemia in multiple myeloma. A case report].
Streuli R; Voellmy W
Schweiz Med Wochenschr; 1987 Feb; 117(8):286-91. PubMed ID: 3470922
[TBL] [Abstract][Full Text] [Related]
17. Acute leukemia after chemotherapy (melphalan).
Einhorn N
Cancer; 1978 Feb; 41(2):444-7. PubMed ID: 272946
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
19. Therapy related acute non-lymphocytic leukemia: report of 4 cases.
Atichartakarn V; Punyammalee B; Nitiyanant P
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):421-30. PubMed ID: 4095607
[TBL] [Abstract][Full Text] [Related]
20. [Tumor-induction through cytostatic agents in man].
Hunstein W; Rehn K
Dtsch Med Wochenschr; 1975 Jan; 100(4):155-8. PubMed ID: 1053991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
